 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Pfizer, Shire Pulled into Isis Suit Against Santaris with Subpoena Dispute
March 14, 2013
Pfizer, Shire Pulled into Isis Suit Against Santaris with Subpoena Dispute
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pfizer Aims to Head Off Court Hearing over Isis, Santaris Patent Dispute
April 11, 2013 / Gene Silencing News - Court Denies Santaris Bid to End Isis Patent-Infringement Case
September 27, 2012 / Gene Silencing News - Oligo Drugs Advance in the Clinic in 2012 as Delivery Hurdles are Addressed
January 3, 2013 / Gene Silencing News - Santaris Seeks Dismissal of Isis Patent-Infringement Suit
February 2, 2012 / Gene Silencing News - Isis, Roche Partner on Huntington’s Disease Drug Program
April 11, 2013 / Gene Silencing News